George Matsopoulos | Medical Imaging | Best Researcher Award

Prof. George Matsopoulos | Medical Imaging | Best Researcher Award

Mengchao Wei | Venous thromboembolism | Best Researcher Award

Dr. Mengchao Wei | Venous thromboembolism | Best Researcher Award

Dr. Mengchao Wei, Peking Union Medical College Hospital, China

Dr. Mengchao Wei is a physician at Peking Union Medical College Hospital, China, specializing in Urology. He graduated with a Doctor’s degree from Sun Yat-sen University in 2019. Since joining PUMCH in 2021, Dr. Wei has focused on optimizing perioperative management for urologic surgeries. He developed a predictive model for venous thromboembolism risk post-surgery, now integrated into clinical practice. Dr. Wei has published 10 journal articles in SCI and Scopus indexed journals. His research aims to improve patient safety and surgical outcomes, making significant contributions to the field of urologic surgery.

Author Profile

Orcid Profile

📚Early Academic Pursuits: 

Dr. Mengchao Wei graduated with a Doctor’s degree from Sun Yat-sen University in 2019. His academic journey laid the foundation for his current work, particularly in the field of Urology, where he became deeply involved in understanding the nuances of perioperative management in urologic surgeries. His comprehensive training and early research set him on a path to clinical excellence and innovation.

⚕️Professional Endeavors and Contributions: 

Since 2021, Dr. Wei has been practicing as a Physician at Peking Union Medical College Hospital, where his focus lies in the optimization of perioperative management in urologic surgeries. His clinical work has had a direct impact on improving patient care and the efficiency of surgical outcomes. Dr. Wei’s contributions include the development of a predictive model for venous thromboembolism risk following urologic surgeries, which has been implemented in real-world clinical practice to enhance patient safety.

🔬Research Focus and Innovations on Venous thromboembolism:

Dr. Wei’s research centers on perioperative management within urology, particularly concerning venous thromboembolism (VTE) risk. His predictive model for VTE risk, now utilized in clinical settings, showcases his ability to translate research into tangible, life-saving outcomes. While his citation index stands at 10, his work continues to gain attention in the medical community. He has published 10 journals in esteemed databases such as SCI and Scopus, reinforcing his status as a respected figure in urologic research.

🌍Impact and Influence: 

Dr. Wei’s contributions have not only benefited his hospital but also shaped the way urologic surgeries are managed perioperatively. By providing a tool that enhances clinical decision-making, he directly improves surgical outcomes, patient safety, and overall healthcare efficiency. His work has influenced peers, setting a new standard in the field of urology.

📑Academic Citations:

Dr. Wei has an impressive citation index of 10, a reflection of the growing recognition of his work and the clinical value it brings. His research continues to receive acknowledgment in relevant medical journals, contributing to the advancement of perioperative care in urology.

🚀Legacy and Future Contributions: 

Dr. Wei’s research and innovations indicate a promising future in the field of urology. He is committed to enhancing perioperative management for urologic surgeries and advancing clinical practices. Moving forward, his aim is to refine predictive models and further contribute to patient safety and surgical excellence.

🌟Conclusion:

Dr. Mengchao Wei’s work at Peking Union Medical College Hospital has made a significant impact on perioperative management in urologic surgeries. His predictive model for venous thromboembolism risk has been successfully integrated into clinical practice, improving patient outcomes and safety. With 10 journal publications in SCI and Scopus indexed journals, Dr. Wei is recognized as a dedicated and innovative physician. His contributions are shaping the future of urologic surgery. As he continues to push the boundaries of medical research, his work promises to enhance the quality of care and patient safety worldwide.

Top Notable Publications 

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries

Authors: Mengchao Wei

Journal: Scientific Reports

Year: 2025

The role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinoma

Authors: Mengchao Wei

Journal: BMC Urology

Year: 2024

Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial

Authors: Mengchao Wei

Journal: World Journal of Urology

Year: 2024

Surgery or external beam radiation for solitary small hepatocellular carcinoma

Authors: Mengchao Wei

Journal: Journal of Cancer Research and Therapeutics

Year: 2023

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy

Authors: Mengchao Wei

Journal: Frontiers in Oncology

Year: 2022

Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2022

The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer

Authors: Mengchao Wei

Journal: International Journal of Radiation Oncology, Biology, Physics

Year: 2022

Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A

Authors: Mengchao Wei

Journal: Annals of Surgical Oncology

Year: 2020

Radiofrequency ablation plus nucleotide analogues for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis

Authors: Mengchao Wei

Journal: American Journal of Translational Research

Year: 2018

Sorafenib versus Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Authors: Mengchao Wei

Journal: BMC Cancer

Year: 2018

xie zhengxing | Cardiovascular Disease | Best Research Article Award

Prof. xie zhengxing | Cardiovascular Disease | Best Research Article Award 

Xiaodong Jiang | Critical Care Medicine | Best Researcher Award

Mr. Xiaodong Jiang | Critical Care Medicine | Best Researcher Award 

Mr. Xiaodong Jiang, Second Affiliated Hospital of Dalian Medical University, China

Mr. Xiaodong Jiang is a Chief Physician and Doctoral Researcher in Critical Care Medicine at the Second Affiliated Hospital of Dalian Medical University, China. As Deputy Director of the Critical Care Medicine Department, he excels in ECMO techniques and the management of severe and complex critical conditions. He is also a Master’s Supervisor, Party Branch Secretary, and Deputy Director of the Critical Care Medicine Teaching and Research Office. Actively involved in national and regional medical committees, he contributes to advancing critical care practices and education. His work in clinical innovation and academic leadership establishes him as a prominent expert in critical care medicine.

Author Profile

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Mr. Jiang Xiaodong embarked on his academic journey with a clear focus on critical care medicine, quickly distinguishing himself as a dedicated scholar. His early studies laid the foundation for his expertise in managing life-threatening conditions, paving the way for his role as a Chief Physician and Doctoral Researcher. His academic excellence and commitment to learning were evident as he advanced through rigorous medical training and specialized in critical care medicine.

🩺PROFESSIONAL ENDEAVORS:

Mr. Jiang serves as the Deputy Director of the Critical Care Medicine Department and Deputy Director of the Critical Care Medicine Teaching and Research Office at the Second Affiliated Hospital of Dalian Medical University. In these roles, he combines clinical expertise with administrative responsibilities, ensuring the seamless functioning of critical care units and fostering innovation in patient care.

Additionally, as the Secretary of the Critical Care Medicine Party Branch, he demonstrates exemplary leadership, influencing policies and practices within the hospital’s critical care division.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CRITICAL CARE MEDICINE:

Mr. Jiang’s research focus includes groundbreaking work in ECMO (Extracorporeal Membrane Oxygenation) treatment techniques, such as VV-ECMO, VA-ECMO, and ECPR. His expertise has revolutionized the management of severe pneumonia, emergency PCI, and perioperative care for lung transplants.

His contributions extend to the development of advanced rescue strategies for critical conditions, solidifying his status as a leading innovator in critical care medicine. His research findings have practical applications, improving patient survival rates and recovery outcomes.

🌟IMPACT AND INFLUENCE 

Through his academic and professional positions, Mr. Jiang has significantly influenced critical care medicine at both regional and national levels. His active membership in various medical committees, including the Chinese Medical Doctor Association and Liaoning Medical Association, highlights his role in shaping critical care policies and advancing best practices.

His leadership extends to academic and clinical education, mentoring young professionals, and fostering the next generation of critical care specialists.

📝ACADEMIC CITES AND EDITORIAL CONTRIBUTIONS: 

Mr. Jiang is a recognized authority in his field, serving as an invited reviewer for prestigious journals, including the Chinese Journal of Emergency Medicine and the Chinese Journal of Critical Care Medicine.

As an Editorial Board Member of the Chinese Journal of Postgraduate Medical Education, he ensures the dissemination of high-impact research, further enhancing the academic landscape of critical care medicine.

🌍LEGACY AND FUTURE CONTRIBUTIONS: 

Mr. Jiang’s legacy is defined by his unwavering commitment to advancing critical care medicine. His work in ECMO techniques, patient-centered care, and innovative research sets a benchmark for excellence.

Looking to the future, Mr. Jiang is poised to continue his groundbreaking research and expand his influence, leaving an indelible mark on critical care medicine. His dedication inspires colleagues and students alike, ensuring that his contributions will resonate for years to come.

🏆FINAL REMARKS AND RECOGNITION:

Mr. Jiang Xiaodong embodies the qualities of a distinguished researcher, clinician, and academic leader. His comprehensive achievements in critical care medicine make him a deserving candidate for any accolade recognizing excellence and innovation in medical science. Recognizing his contributions will not only honor his work but also inspire continued progress in the field of critical care medicine.

🌟CONCLUSION:

Mr. Xiaodong Jiang stands as a beacon of excellence in critical care medicine, seamlessly blending clinical expertise, academic leadership, and innovative research. His groundbreaking work in ECMO techniques and dedication to improving patient outcomes have set new standards in the field. Through his roles in education and professional organizations, he continues to inspire the next generation of medical professionals.

With his unwavering commitment to advancing critical care practices, Mr. Jiang’s contributions will leave a lasting impact on the medical community. He is a true leader and innovator, deserving of recognition and admiration.

TOP NOTABLE PUBLICATIONS:

Machine learning for predicting acute myocardial infarction in patients with sepsis

Authors: Fang, S., Jin, H., Zhang, J., Su, W., Jiang, X.

Journal: Scientific Reports

Year: 2024

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis

Authors: Gong, D., Yu, J., Jiang, X.

Journal: Frontiers in Oncology

Year: 2022

Effect of MIR-26a targeting GSK-3β/β-catenin signaling pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion

Authors: Gong, D.-D., Yu, J., Yu, J.-C., Jiang, X.-D.

Journal: European Review for Medical and Pharmacological Sciences

Year: 2019

Takotsubo-like cardiomyopathy in a giant pheochromocytoma

Authors: Zhu, D., Yu, J., Li, X., Jiang, X., Zhuang, C.

Journal: International Journal of Cardiology

Year: 2014